NEWS

Our Latest News

ARCHIMED finalizes the acquisition of IBA Lifesciences GmbH by Cube Biotech

ARCHIMED finalizes the acquisition of IBA Lifesciences GmbH by Cube Biotech

The acquisition represents a transformational transaction for Cube, bringing critical size, complementing Cube’s protein purification portfolio, reinforcing its market position and boosting its profitability.

ARCHIMED finalizes the acquisition of IBA Lifesciences GmbH by Cube Biotech

Majority owner ARCHIMED and partners CAPZA and Siparex finance add-on acquisition by European safety testing company – and French market leader – CARSO

 March

 16, 

2023

ARCHIMED buys WiQo, a pioneer in the field of aesthetic medicine

 March

 9, 

2023

ARCHIMED invests in PlasmidFactory, a German gene and cell therapy specialist

 October

 7, 

2022

ARCHIMED Impact Report 2021 – Investing for Better Healthcare: a Global Challenge

 October

 4, 

2022

ARCHIMED acquires Nasdaq-listed Natus Medical Incorporated in $1.1 billion take-private deal

 July

 21, 

2022

ARCHIMED invests in Title21 Health Solutions, a leading US-based healthcare software provider

 July

 12, 

2022

1 2 3 4 5 6 … 15
368